PIRAMAL PHARMA
|
The Current P/B Ratio of PIRAMAL PHARMA is 3.95.
Share Price | ₹234.9 | Jan 14,2025 |
Market Cap | ₹31,134.1 Cr | |
Book Value | ₹7,883.9 Cr | Mar2024 - Consolidated Results |
Price/Book | 3.95x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of PIRAMAL PHARMA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹31,134.1 Cr] as on Jan 14,2025
(/) Book Value [ ₹7,883.9 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 3.95x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '3.95 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/B Ratio of PIRAMAL PHARMA over the last five years.
Historical PB (Price/Book ) ratio chart of PIRAMAL PHARMA
PB Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/b ratio for fiscal years ending Mar2024 to Mar2021 averaged 0.84x.
- PIRAMAL PHARMA 's operated at median p/b ratio of 1.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/b ratio peaked in Mar2024 at 2.16x.
- PIRAMAL PHARMA 's p/b ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
PIRAMAL PHARMA | 7,883.90 | 3.95 | 31,134.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.67 | 424,382.0 |
CIPLA LTD | 26,619.90 | 4.39 | 116,943.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.97 | 111,588.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.08 | 100,704.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.73 | 159,224.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.80 | 110,215.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.06 | 110,142.0 |
LUPIN LTD | 14,175.80 | 6.94 | 98,330.0 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.29 | 68,238.4 |
ABBOTT INDIA LTD | 3,658.73 | 16.41 | 60,041.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PIRAMAL PHARMA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.29x |
Max industry PB | 16.41x |
Median industry PB | 6.67x |
Average industry PB | 8.12x |
You may also like the below Video Courses